Abstract
A multistep proteomics fractionation strategy was developed and validated for the discovery of proteomic biomarkers which could be used as potential diagnostic biomarkers for monitoring the progression of disease in smokers and COPD patients towards lung cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have